Podcast
MSL Talk: Tom Caravela, Trish Gorecki
People First… Business Second
Summary
In this episode, Tom Caravela is joined by Mark Freebery and Rachel Pater to explore the vital role of team culture in the MSL field. They discuss a people-first business philosophy and how fostering the right environment can significantly impact team dynamics. The conversation highlights the influence MSLs have on shaping culture and the importance of recognizing and building individualized connections. The episode delves into assessing cultural fit during interviews and ensuring psychological safety within teams. Additionally, they address balancing personal and professional boundaries and share strategies for professional development, concluding with remarks on the importance of team culture.
Mark Freebery, MSL Regional Director East, and Rachel Pater, Community Medical Liaison Director, West at Syneos Health discuss the importance of investing in people and putting interpersonal relationships first, business second.
Mark and Rachel share…
👉 The importance and benefits of great team culture
👉 Why leaders need to invest in people
👉 What MSLs can do to influence great team culture
👉 Why and how to develop stronger interpersonal relationships
👉 What is “psychological safety” and why is it important
👉 Great examples of professional development programs for MSL teams
MSL field, team culture, interpersonal relationships, professional development, psychological safety
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Trish Gorecki
Podcast
MSL Talk: Tom Caravela
What is the ONE Word?
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary